N-Nitroso Edoxaban Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds.Edoxaban is used to prevent stroke and blood clots in patients with a certain heart rhythm problem (eg, nonvalvular atrial fibrillation). Edoxaban is also used to treat deep venous thrombosis, a condition in which harmful blood clots form in the blood vessels of the legs.N-Nitroso Edoxaban Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Edoxaban Impurity 1 chemically represented as 5-nitroso-4,5,6,7- tetrahydrothiazolo[5,4-c] pyridin-2-amine.Synchemia is the leading manufacturing and exporter of N-Nitroso Edoxaban Impurity 1 .We supply N-Nitroso Edoxaban Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N014919 |
| CAS No | NA |
| Mol.F. | C16H12N6O3 |
| Mol.Wt. | 336.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014920 |
| CAS No | NA |
| Mol.F. | C28H28N8O2 |
| Mol.Wt. | 508.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014921 |
| CAS No | 2816369-80-7 |
| Mol.F. | C28H28N8O2 |
| Mol.Wt. | 508.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014922 |
| CAS No | NA |
| Mol.F. | C16H14N6O |
| Mol.Wt. | 306.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014923 |
| CAS No | NA |
| Mol.F. | C24H24ClFN6O4 |
| Mol.Wt. | 514.9 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014924 |
| CAS No | NA |
| Mol.F. | C23H22ClFN6O4 |
| Mol.Wt. | 500.9 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014925 |
| CAS No | NA |
| Mol.F. | C26H29N7O4 |
| Mol.Wt. | 503.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014926 |
| CAS No | NA |
| Mol.F. | C26H28N8O5 |
| Mol.Wt. | 532.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014927 |
| CAS No | NA |
| Mol.F. | C26H29N7O4 |
| Mol.Wt. | 503.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014928 |
| CAS No | NA |
| Mol.F. | C30H33N5O3 |
| Mol.Wt. | 511.6 |
| INV STATUS | In Stock |
| CAT No | SRC-N014929 |
| CAS No | NA |
| Mol.F. | C30H28N5O3 |
| Mol.Wt. | 506.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014930 |
| CAS No | NA |
| Mol.F. | C17H15F6N3O2 |
| Mol.Wt. | 407.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014931 |
| CAS No | NA |
| Mol.F. | C28H32N8O3 |
| Mol.Wt. | 528.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014932 |
| CAS No | NA |
| Mol.F. | C27H30N8O3 |
| Mol.Wt. | 514.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014933 |
| CAS No | NA |
| Mol.F. | C27H30N8O3 |
| Mol.Wt. | 514.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014934 |
| CAS No | NA |
| Mol.F. | C27H30N8O3 |
| Mol.Wt. | 514.6 |
| INV STATUS | CUSTOM SYNTHESIS |